HyungsubShimMD

Neurology • Iowa City, IA

Vascular Neurology, Neurodegenerative, Dementia & Geriatrics

"Director: Memory Disorders Clinic Medical Director: Neuroscience Intermediate Care Unit Clinical Assistant Professor of Neurology Clinical Assistant Professor of Psychiatry University of Iowa Hospitals and Clinics"

Join to view full profile

Dr. Shim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shim's full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-356-1616

Fax+1 319-384-7199

Education & Training

Northwestern Memorial HospitalBehavioral neurology and neuropsychiatry, 2010 - 2012
University of Iowa Hospitals and ClinicsResidency, Neurology, 2007 - 2010
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2006 - 2007
Medical College of WisconsinClass of 2006

Certifications & Licensure

IA State Medical License 2012 - 2026
IL State Medical License 2010 - 2026
American Board of Psychiatry and Neurology Neurology
United Council of Neurologic SubspecialtiesBehavioral Neurology and Neuropsychiatry

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

ADNI: Alzheimer's Disease Neuroimaging Initiative Start of enrollment: 2005 Jul 01
Completed
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients Start of enrollment: 2005 Sep 01
Completed
Phase 2
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia Start of enrollment: 2007 Oct 01
Completed
Phase 4
A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease Start of enrollment: 2007 Dec 01
Completed
Phase 2
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity Start of enrollment: 2010 Apr 01
Completed
Alzheimer's Disease Neuroimaging Initiative 2 Start of enrollment: 2011 Feb 14
Completed
A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients Start of enrollment: 2011 Jan 01
Completed
Phase 2
Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss Start of enrollment: 2014 Feb 28
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

6 citations
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta-Analysis.
Malik Ghannam, Mohammad AlMajali, Milagros Galecio-Castillo, Abdullah Al Qudah, Farid Khasiyev
Journal of the American Heart Association. 2023-12-19
94 citations
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Chris Moran, Richard Beare, Wei Wang, Michele L. Callisaya, Velandai Srikanth
Neurology. 2019-02-19
23 citations
Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
Nandakumar Nagaraja, Nudrat Tasneem, Amir Shaban, Sudeepta Dandapat, Uzair Ahmed
Journal of Stroke and Cerebrovascular Diseases. 2018-02-03

Professional Memberships

American Academy of Neurology - AAN
Member